CHC Healthcare Group (TPE:4164)
Taiwan
· Delayed Price · Currency is TWD 43.15
+0.35 (0.82%)
Apr 28, 2025, 1:35 PM CST
CHC Healthcare Group Revenue
In the year 2024, CHC Healthcare Group had annual revenue of 3.60B TWD, down -7.13%. CHC Healthcare Group had revenue of 1.02B in the quarter ending December 31, 2024, a decrease of -29.70%.
Revenue
3.60B
Revenue Growth
-7.13%
P/S Ratio
2.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.60B | -276.56M | -7.13% |
| Dec 31, 2023 | 3.88B | 902.79M | 30.35% |
| Dec 31, 2022 | 2.97B | 534.79M | 21.92% |
| Dec 31, 2021 | 2.44B | -115.35M | -4.51% |
| Dec 31, 2020 | 2.55B | -395.14M | -13.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Polaris Group | 107.00M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |